• This 5-year plan aims to address the domestic and international MDR-TB crisis by building on the success of the U.S. Government's TB strategies and the WHO END TB Strategy while advancing research on this critical issue.

    Learn More
  • Through technical assistance led by the U.S. Agency for International Development (USAID) and our innovative partnership with Johnson & Johnson, we are scaling up multidrug-resistant TB treatment programs in over 25 countries.

    Learn More
  • As the lead U.S. Government agency for global TB care, USAID works with partners to reach every person with TB, cure those in need of treatment and prevent new TB infections.

    Learn More
  • TB and poverty are inextricably linked. Poor individuals are threefold more likely to develop TB, and TB plunges households further into poverty.


At USAID, we focus our investments on strengthening national TB strategies and programs in 22 priority countries with high rates of TB, drug-resistant TB and HIV-associated TB.

Graphic of a man coughing - 10.4 million new cases of TB
Graphic of two pills. 4.3 million TB cases missing out on proper care
Graphic of a pair of lungs. 1.8 million deaths from TB
Graphic of a microscope. 580,000 new drug-resistant TB cases

The U.S. Agency for International Development (USAID) supports high-quality screening, diagnosis and treatment services for millions of people affected by TB and multidrug-resistant tuberculosis (MDR-TB). In Fiscal Year 2015, with investments of $242 million focused primarily in 22 countries with bilateral TB funds, the U.S. Government achieved the following results in collaboration with each country's programs:

  • More than 3.7 million TB cases detected and diagnosed.
  • More than 2.8 million people provided with TB treatment.
  • More than 70,000 people with MDR-TB started on appropriate treatment.

USAID's FY 2015 investments contributed to an estimated 49 million lives saved from 2000-2015, including people co-infected with HIV and AIDS, leading to a 22 percent decline in TB mortality and a 21 percent decline in TB incidence globally since 2000.


What We Do

USAID works with partner governments to:

  • Prevent TB transmission and renew efforts to find the missing TB cases
  • Strengthen the capacity of national TB programs
  • Build country capacity to use existing resources and to turn evidence into policy
  • Expand the development of new TB diagnostics, drugs and vaccines